Most people still think gout is a lifestyle condition caused primarily by diet. But this belief is a big reason patients have been underserved for decades. In this episode of Power to the Patients, Brandon Li sits down with James Mackay, CEO and co-founder of Crystalys Therapeutics, to explore what gout patients really need. They unpack what went wrong with Zurampic, why Dotinurad’s profile gives Crystalys Therapeutics a reason to come back to gout and how better trial design could finally move the field beyond old assumptions.
For decades, gout has often been framed as a disease caused by lifestyle choices. This episode reframes the conversation entirely.
Podden och tillhörande omslagsbild på den här sidan tillhör
Brandon Li. Innehållet i podden är skapat av Brandon Li och inte av,
eller tillsammans med, Poddtoppen.
